Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
If you have already used semaglutide or tirzepatide and either plateaued or found the results insufficient, retatrutide triple-receptor mechanism offers a genuinely different pharmacological approach that may break through where single or dual agonists hit their ceiling
In addition, Viking Therapeutics is developing VK2809, a novel thyroid hormone receptor beta agonist, for NASH
If you dont have insurance or choose not to use it, you can still save using this form or text SAVE to 83757
It works by helping the pancreas release a controlled amount of hormones, which slows the rate of food leaving the stomach, leaving you fuller for longer
Your prescriber may increase further to 1 mg or 2 mg, depending on your response
In Phase 3, it produced 28.7% weight loss the most ever seen in a large obesity trial
US$ 22.57
US$ 25.14
US$ 24.50
US$ 22.29
US$ 23.41
US$ 23.21
US$ 23.29
